NEWS:
LATEST STUDIES:
Search result
4 Results found
Use of biosynthetic growth hormone in children of short stature. Investigation of cardiovascular effects
Phase II/III, open label, multi-center clinical trial to evaluate the safety and efficacy of insulin-like growth factor 1/ insulin like growth factor binding protein-3 (rhIGF-1/GFBP-3)
Estudio de nuevos marcadores de función adipocitaria (Leptina, Adiponectina y Resistita) y Ghrelina en población infantil deficitaria de GH. Evaluación del efecto de la administración exógena de somatropina recombinante sobre dichos marcadores, en niños tratados según condiciones asistenciales de uso.
Study of new markers of adipocyte function (Leptin, Adiponectin and Resistita) and Ghrelin in children with GH deficiency. Evaluation of the effect of the exogenous administration of recombinant somatropin on these markers in children treated as usually in clinical practice.
A Phase III, Open-Label, Multi-Center Clinical Trial to Evaluate the Safety and Efficacy of Insulin-Like Growth Factor I/ Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/ rhIGFBP-3), administered for 12 Months in Children and Adolescents with Growth Hormone Insensitive Syndrome (GHIS) such a Laron Syndrome
Results 4 of 4 found
1